Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastric mucus and mucosal glycoproteins, primarily Mucin-5AC (MUC5AC) and Mucin-6 (MUC6), constitute the primary physical barrier protecting the stomach lining from autodigestion by gastric acid and pepsin (StatPearls, 2023). MUC5AC is secreted by surface mucous cells, while MUC6 is produced by mucous neck cells, together forming a viscoelastic gel that traps bicarbonate ions to maintain a near-neutral pH at the epithelial surface (PubMed, PMID: 15153509). In pathological states such as peptic ulcer disease or Helicobacter pylori infection, the integrity of this glycoprotein matrix is often compromised, leading to mucosal erosion and inflammation (NIH, 2022). Therapeutic agents known as cytoprotective drugs, including sucralfate and rebamipide, interact with these glycoproteins to reinforce the barrier or stimulate their synthesis (PubChem, CID 5284595). Sucralfate, for instance, forms a polyanionic complex that binds to positively charged proteins and glycoproteins within ulcerated tissue, creating a protective bandage against further chemical injury (StatPearls, 2023).
Binding to mucosal glycoproteins to form a protective physical barrier; stimulation of endogenous prostaglandin-mediated mucus and bicarbonate secretion; enhancement of glycoprotein synthesis and sulfation to improve gel viscosity (StatPearls, 2023; PubMed, PMID: 15153509).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastric mucus and mucosal glycoproteins (MUC5AC/MUC6).